A carregar...
Rationale for azithromycin in COVID-19: an overview of existing evidence
Azithromycin has rapidly been adopted as a repurposed drug for the treatment of COVID-19, despite the lack of high-quality evidence. In this review, we critically appraise the current pharmacological, preclinical and clinical data of azithromycin for treating COVID-19. Interest in azithromycin has b...
Na minha lista:
| Publicado no: | BMJ Open Respir Res |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7811960/ https://ncbi.nlm.nih.gov/pubmed/33441373 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjresp-2020-000806 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|